To dissect the molecular mechanisms of CD83 in the fate determination of ovarian cancer cells, we used the immunoprecipitation, followed by mass spectrometry (IP-MS) approach, to identify protein candidates that functionally associate with transmembrane CD83 (Figure 5a). Here, CD83 is linked to ovarian carcinoma.